Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Origa

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Haematologica|July 5, 2006
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overloadAntonio Piga, Renzo Galanello, Gian Luca Forni, et al.
Journal of Clinical Medicine|February 13, 2025
Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good PracticeValeria Maria Pinto, Rosanna Cima, Rosario Di Maggio, et al.
Blood Transfusion = Trasfusione Del Sangue|November 16, 2020
Changing patterns of thalassaemia in Italy: a WebThal perspectiveFilomena Longo, Paola Corrieri, Raffaella Origa, et al.
Blood|January 5, 2022
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterizationValeria Maria Pinto, Khaled M Musallam, Giorgio Derchi, et al.
Haematologica|March 3, 2022
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemiaGiorgio Derchi, Khaled M Musallam, Valeria Maria Pinto, et al.
American Journal of Hematology|September 21, 2017
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathiesRaffaella Origa, Maria Laura Ponti, Aldo Filosa, et al.
Blood Advances|January 22, 2026
Atrial fibrillation prevalence and its management in aging transfusion-dependent thalassemia patients: the FATHAL studyValeria Di Stefano, Barbara Gianesin, Valeria Orecchia, et al.
Cancer|March 14, 2023
Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies"Raffaella Origa, Barbara Gianesin, Filomena Longo, et al.
Haematologica|October 20, 2018
Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding studyMaria Domenica Cappellini, John Porter, Raffaella Origa, et al.
Haematologica|December 7, 2014
A genetic score for the prediction of beta-thalassemia severityFabrice Danjou, Marcella Francavilla, Franco Anni, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Haematologica|July 5, 2006
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overloadAntonio Piga, Renzo Galanello, Gian Luca Forni, et al.
Journal of Clinical Medicine|February 13, 2025
Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good PracticeValeria Maria Pinto, Rosanna Cima, Rosario Di Maggio, et al.
Blood Transfusion = Trasfusione Del Sangue|November 16, 2020
Changing patterns of thalassaemia in Italy: a WebThal perspectiveFilomena Longo, Paola Corrieri, Raffaella Origa, et al.
Blood|January 5, 2022
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterizationValeria Maria Pinto, Khaled M Musallam, Giorgio Derchi, et al.
Haematologica|March 3, 2022
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemiaGiorgio Derchi, Khaled M Musallam, Valeria Maria Pinto, et al.
American Journal of Hematology|September 21, 2017
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathiesRaffaella Origa, Maria Laura Ponti, Aldo Filosa, et al.
Blood Advances|January 22, 2026
Atrial fibrillation prevalence and its management in aging transfusion-dependent thalassemia patients: the FATHAL studyValeria Di Stefano, Barbara Gianesin, Valeria Orecchia, et al.
Cancer|March 14, 2023
Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies"Raffaella Origa, Barbara Gianesin, Filomena Longo, et al.
Haematologica|October 20, 2018
Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding studyMaria Domenica Cappellini, John Porter, Raffaella Origa, et al.
Haematologica|December 7, 2014
A genetic score for the prediction of beta-thalassemia severityFabrice Danjou, Marcella Francavilla, Franco Anni, et al.
Pageof 10